Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
Sign in with Google. Opens in new tab
ENTITY
MatsukiyoCocokara (3088 JP)
Watchlist
112
Analysis
Consumer Staples
•
Japan
MatsukiyoCocokara & Co. operates drug store chains. The Company retails medicines, cosmetics, health foods, beauty care products, and other products. MatsukiyoCocokara & also operates supermarkets and home centers.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Tsuruha Holdings
•
28 Feb 2024 11:40
Aeon (8267 JP), Tsuruha (3391 JP) And Welcia (3141 JP)’s Long-Dated Plan
We prefer to play these transactions through Tsuruha due to a valuation benchmark (Aeon’s acquisition from Oasis at JPY15,500) and undemanding...
Arun George
Follow
315 Views
Share
bullish
•
Tsuruha Holdings
•
26 Feb 2024 21:11
Aeon, Welcia and Tsuruha: Creating an FMCG Behemoth
Merger between Welcia and Tsuruha under Aeon may happen as FMCG-drugstores increasingly compete with supermarkets and CVS, so we need to view the...
Michael Causton
Follow
424 Views
Share
bullish
•
Tsuruha Holdings
•
26 Feb 2024 11:05
Activists May Be Pushing Tsuruha Towards a Merger with Welcia
This insight from last September looked at the likelihood of a merger attempt by Aeon between Welcia and Tsuruha. The reasons for this are similar...
Michael Causton
Follow
631 Views
Share
bullish
•
Tsuruha Holdings
•
26 Feb 2024 06:10
Tsuruha (3391) And Welcia (3141) - Aeon Tsuruha Stake Buy Followed by Merger?
Over the weekend we have news suggesting Aeon is pushing Tsuruha and Welcia towards a merger after buying Oasis' Tsuruha stake. Both stocks are up....
Travis Lundy
Follow
701 Views
Share
bullish
•
Thematic (Sector/Industry)
•
01 Feb 2024 03:00
Japan Retail Update: Winners and Losers as FY2023 Ends
Summary: Japan's retail sectors in 2023 saw drugstore consolidation and encroachment on supermarkets, while dept. stores and lifestyle retailing...
Michael Causton
Follow
346 Views
Share
First
Previous
1
2
3
4
5
6
7
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.53.5
x